pubmed-article:9850747 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C0007807 | lld:lifeskim |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C1880904 | lld:lifeskim |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C0009952 | lld:lifeskim |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
pubmed-article:9850747 | lifeskim:mentions | umls-concept:C1518422 | lld:lifeskim |
pubmed-article:9850747 | pubmed:issue | 3B | lld:pubmed |
pubmed-article:9850747 | pubmed:dateCreated | 1999-3-16 | lld:pubmed |
pubmed-article:9850747 | pubmed:abstractText | Febrile seizures are the commonest acute neurological disorder of early childhood. Studies suggested that febrile seizures are previous acute events from a more serious neurological problem. Due to neuron-specific enolase is generally accepted as a marker for neuropathological processes in the brain, 16 pediatric patients were studied during their first seizures and a year after it. Neuron-specific enolase in cerebrospinal fluid and blood were analysed by an immune enzyme assay. Non pathological neuron-specific enolase values were obtained in both periods in the group of patients. There were no significative differences when paired series statistics test was performed with 95% of confidence. Neuron-specific enolase appears not to be a marker for febrile seizures because its concentration not be increased in cerebrospinal fluid in this group of patients. | lld:pubmed |
pubmed-article:9850747 | pubmed:language | eng | lld:pubmed |
pubmed-article:9850747 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9850747 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9850747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9850747 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9850747 | pubmed:month | Sep | lld:pubmed |
pubmed-article:9850747 | pubmed:issn | 0004-282X | lld:pubmed |
pubmed-article:9850747 | pubmed:author | pubmed-author:ReiberHH | lld:pubmed |
pubmed-article:9850747 | pubmed:author | pubmed-author:Dorta-Contrer... | lld:pubmed |
pubmed-article:9850747 | pubmed:author | pubmed-author:Tabío-ValdésE... | lld:pubmed |
pubmed-article:9850747 | pubmed:author | pubmed-author:Tabío-ValdésA... | lld:pubmed |
pubmed-article:9850747 | pubmed:author | pubmed-author:Delgado-Ferná... | lld:pubmed |
pubmed-article:9850747 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9850747 | pubmed:volume | 56 | lld:pubmed |
pubmed-article:9850747 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9850747 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9850747 | pubmed:pagination | 540-4 | lld:pubmed |
pubmed-article:9850747 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
pubmed-article:9850747 | pubmed:meshHeading | pubmed-meshheading:9850747-... | lld:pubmed |
pubmed-article:9850747 | pubmed:meshHeading | pubmed-meshheading:9850747-... | lld:pubmed |
pubmed-article:9850747 | pubmed:meshHeading | pubmed-meshheading:9850747-... | lld:pubmed |
pubmed-article:9850747 | pubmed:meshHeading | pubmed-meshheading:9850747-... | lld:pubmed |
pubmed-article:9850747 | pubmed:meshHeading | pubmed-meshheading:9850747-... | lld:pubmed |
pubmed-article:9850747 | pubmed:meshHeading | pubmed-meshheading:9850747-... | lld:pubmed |
pubmed-article:9850747 | pubmed:meshHeading | pubmed-meshheading:9850747-... | lld:pubmed |
pubmed-article:9850747 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9850747 | pubmed:articleTitle | Non increased neuron-specific enolase concentration in cerebrospinal fluid during first febrile seizures and a year follow-up in pediatric patients. | lld:pubmed |
pubmed-article:9850747 | pubmed:affiliation | Laboratorio Inmunología, Hospital Pediátrico San Miguel, Ciudad Habana, Cuba. | lld:pubmed |
pubmed-article:9850747 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9850747 | pubmed:publicationType | Comparative Study | lld:pubmed |